Mesoblast (MESO) Competitor Comparison
We are evaluating the key criteria listed to compare Mesoblast (MESO) against its competitors in the Biotechnology industry.
Market Capitalization
233 / 368Gross Profits
194 / 278Total Revenue
191 / 300EBITDA
162 / 337Free Cashflow
237 / 352Quick Ratio
295 / 357Earnings per Share
132 / 359Dividend yield
0 / 6Total Cash
241 / 358Performance 3 years
61 / 368Performance 5 years
117 / 368Performance 10 years
156 / 368Linearity 3 years
267 / 368Linearity 5 years
56 / 368Linearity 10 years
163 / 367Total Rank
198 / 368Dividend Rank
204 / 368Valuation Rank
145 / 368Piotroski Rank
86 / 368Muliplier Rank
156 / 368Market Capitalization - MESO ranking 233 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.